“The “authentication at the point of dispensing” pilot has been organized by start-up Aegate and brings together six U.K. pharmaceutical companies – including Merck Generics U.K., Merck Pharmaceuticals, Novartis, Schering Health Care and Solvay – and 50 dispensing outlets, which include hospitals and small pharmacies across England. Aegate says its trial is targeted only at providing pharmacists and doctors with information in a pragmatic way to authenticate products at the point of dispensing. “
You are here: